Prostate cancer screening: And the pendulum swings
نویسندگان
چکیده
منابع مشابه
Management of localized prostate cancer: the pendulum swings (back to the middle)
before and after the advent of PSA screening. The SPCG‑4 trial was conducted between 1989 and 1999, with only 5.2% of cancers detected by PSA. 4 On the other hand, the PIVOT study, conducted between 1994 and 2002, had 75% of cases detected by PSA screening. 5 The impact of PSA screening in these trials cannot be emphasized strongly enough – it is estimated that PSA screening is associated with ...
متن کاملPSA Screening in Prostate Cancer
Introduction: Prostate cancer is one of the most common cancers in Iranian men. PSA(prostate specific antigen) screening is a controversial issue because PSA screening leads to diagnose of patients with low risk prostate cancer who not only do not benefit from treatment but also suffer from complication caused by treatment. On the other hand, without prostate cancer screening, the rate of meta...
متن کاملPendulum swings back to MMR
welcome unanimity in UK media treatment of a recent paper on measles, mumps, rubella (MMR) vaccine in the Archives of Disease in Childhood. This was a review by David Elliman of St George’s Hospital and Helen Bedford of the Institute of Child Health, London, of all the evidence concerning alleged links with autism and inflammatory bowel disease. They concluded that there were no such links –— b...
متن کاملIntrauterine contraception: the pendulum swings back.
Intrauterine contraception is the most widely used method of reversible fertility regulation in the world. Finally, IUC is undergoing a renaissance in the US and it's role will expand as new devices and systems are developed and as old biases among clinicians and women are erased. Successful fertility regulation is a defining factor of the overall health of a population; the expanded use of IUC...
متن کاملProstate Cancer Screening: The Pendulum has Swung, and the Burden of Proof Is with Proponents.
Because prostate cancer screening guidelines have wide implications and generate strong opinions, the debate has spilled outside the pages of the peer-reviewed biomedical literature and into the popular press. In July 2015, Dr. Deepak Kapoor, a urologist, published an op-ed piece in the New York Times entitled, “Bring Back Prostate Screening.”1 In it, he counsels that advances in magnetic reson...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 2018
ISSN: 0008-543X
DOI: 10.1002/cncr.31380